RxDoctor Payments Data

Larry Allen, MD

Family Medicine · Syracuse, INNPI 1942310818

Payments from drug & device makers

$973in general payments, 2019–2025

Across 55 payments — averaging $17.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$210
  • Lilly USA, LLC$174
  • Novartis$99
  • GSK$85
  • Pfizer$79
  • AbbVie$61
  • plus $266 from 11 others

What the payments were for

  • Food & beverage$973100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$973 in reported general payments places this provider in the 60th percentile of 2,709 family medicine providers in Indiana.

See all family medicine providers in Indiana

Medicare billing

Part B allowed, 2024
$12,253
Medicare patients
67
Services billed
437

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ShingrixVaricella-Zoster Ge/As01b/Pf77$17,068
EliquisApixaban16$16,618
XareltoRivaroxaban15$15,994
OzempicSemaglutide11$13,851
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$10,470
AbrysvoRsv Vacc, Pref A And Pref B/Pf22$6,974
JanumetSitagliptin Phos/Metformin Hcl41$2,429
JanuviaSitagliptin Phosphate15$2,178
Potassium Chloride56$1,906
Adacel TdapDiph,pertuss(Acell),tet Vac/Pf24$1,708
Levothyroxine Sodium184$1,452
TradjentaLinagliptin11$1,414
Lantus SolostarInsulin Glargine,hum.Rec.Anlog12$1,274
Atorvastatin Calcium137$1,092
Pantoprazole Sodium178$897

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKShingrix, Trelegy Ellipta$85$27,53893 claims
PfizerEliquis, Abrysvo$79$23,59238 claims
Johnson & JohnsonXarelto$47$15,99415 claims
Novo NordiskOzempic$210$13,85111 claims
MerckJanumet, Januvia$16$4,60756 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,709 family medicine providers in Indiana.

Other family medicine in Syracuse

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →